Investigated various glutathione derivatives in vitro and found that certain forms (e.g., GSHMEE) effectively reduce melanin and tyrosinase activity, increasing the pheomelanin/eumelanin ratio
The results, published in the New England Journal of Medicine, showed participants lost an average of 52 pounds (more than 20% of their weight) on the highest dose of tirzepatide
This is why medical supervision matters
On April 30, 2026 , the FDA proposed leaving semaglutide, tirzepatide, and liraglutide off the 503B bulks list entirely, saying there is no clinical need for large-scale compounding
This includes metabolic monitoring too
Russia: E Bashnina, St Petersburg